SOSV

SOSV, established in 1995 and headquartered in Princeton, New Jersey, is a global venture capital firm specializing in early-stage investments. It focuses on deep tech innovations in the health and environmental sectors, supporting founders with breakthrough technologies through its HAX and IndieBio startup development programs. SOSV provides resources, facilities, and lab equipment to accelerate product development and scale, with a track record of helping its portfolio companies secure subsequent funding rounds led by top-tier investors.

Hugh Bowen

Associate

Weichang Ge

Analyst

Bradford Higgins

Venture Partner

Katie Hoffman

General Partner

Mohan Iyer

General Partner

Benjamin Joffe

Partner

Ji Ke

Partner

Stephen McCann

CFO and General Partner

Carthach McCarthy

CFO

Paul Monaghan

Principal

Brian Murphy

Finance Director

Eric Ramsay

Analyst

Sabriya Stukes Ph.D

Partner

Past deals in 3D Printing

Prellis Biologics

Series C in 2025
Prellis Biologics, Inc. specializes in creating human tissues for drug development and the eventual production of human organs for transplantation. Founded in 2016 and based in San Francisco, California, the company employs advanced bioprinting technology to develop vascularized human tissues and organs, aiming to overcome the challenges associated with microvasculature. Its innovative products include TissueWorkshop, Organoids, Vascular Bundles, Tissue Chips, and Holograph X. Prellis Biologics also focuses on accurately replicating the human immune response through lymph node organoids, which can be utilized for various applications such as antibody discovery and immunogenicity assessment. By addressing critical issues in early-stage drug development and translational pharmacology, Prellis Biologics seeks to improve patient outcomes in healthcare.

BioSapien

Seed Round in 2024
BioSapien is a pre-clinical biotechnology company focused on creating innovative biodegradable implantable products for oncology applications. The company is developing a 3D-printed drug delivery platform that utilizes a biodegradable mesh to deliver active pharmaceutical ingredients (APIs) directly to tumor sites, thereby minimizing systemic side effects associated with traditional therapies. Their flagship product, the MediChip, is designed to administer FDA-approved high-dose systemic therapies in a localized and sustained manner, enhancing the quality of patient care. Current research is focused on applications for pancreatic and lung cancers, with plans to expand the pipeline to include other types such as colorectal, breast, and stomach cancers. By targeting drug delivery directly to cancerous tissues, BioSapien aims to improve treatment efficacy while reducing toxicity for patients.

Terran Robotics

Pre Seed Round in 2024
Terran Robotics is a construction company based in Bloomington, Indiana, that focuses on innovative home construction services, particularly in automated adobe wall building. The company utilizes artificial intelligence and robotics to enhance traditional earthen building techniques. By employing a custom-designed cable-driven robot for three-dimensional printing of homes, Terran Robotics aims to improve durability with features such as fire resistance and superior sound dampening. This approach enables clients to significantly reduce housing costs, lower energy expenses, and maintain an environmentally friendly footprint.

unspun

Series B in 2024
Unspun, Inc., founded in 2015 and based in San Francisco, California, specializes in the development of a platform that creates customized jeans using advanced body scanning technology, fit algorithms, and additive manufacturing. The company aims to address environmental concerns by reducing global carbon emissions through automated and localized manufacturing processes. Unspun’s innovative approach not only eliminates pattern-cutting waste and unsold inventory but also allows for the production of jeans in under ten minutes in a zero-waste manner. Their technology is showcased through the unspun.io platform, which provides digital customization solutions for various apparel brands. With a mission to make fashion more sustainable, Unspun is positioned at the intersection of robotics and digital apparel, striving to transform the industry with its unique approach to on-demand manufacturing.

3DK Tech

Seed Round in 2023
3DK Tech, located at HAX, specializes in advanced metal 3D printing technology aimed at enhancing manufacturing processes for various industries, including aerospace, medical, and automotive. The company has developed a proprietary method that improves the selective laser melting (SLM) process, allowing for the production of complex parts with exceptional precision and efficiency. This innovation offers significant advantages, delivering parts that are 200 times more durable, produced 10 times faster, and at a cost 10 times more effective than traditional manufacturing methods. By focusing on aviation maintenance, repair, and operations (MRO), 3DK Tech provides businesses with the ability to create high-quality components that meet rigorous industry standards.

AtoMe

Seed Round in 2023
AtoMe is a manufacturing company that develops enhanced-performance materials for metal additive manufacturing.

Prellis Biologics

Series C in 2023
Prellis Biologics, Inc. specializes in creating human tissues for drug development and the eventual production of human organs for transplantation. Founded in 2016 and based in San Francisco, California, the company employs advanced bioprinting technology to develop vascularized human tissues and organs, aiming to overcome the challenges associated with microvasculature. Its innovative products include TissueWorkshop, Organoids, Vascular Bundles, Tissue Chips, and Holograph X. Prellis Biologics also focuses on accurately replicating the human immune response through lymph node organoids, which can be utilized for various applications such as antibody discovery and immunogenicity assessment. By addressing critical issues in early-stage drug development and translational pharmacology, Prellis Biologics seeks to improve patient outcomes in healthcare.

BioSapien

Convertible Note in 2023
BioSapien is a pre-clinical biotechnology company focused on creating innovative biodegradable implantable products for oncology applications. The company is developing a 3D-printed drug delivery platform that utilizes a biodegradable mesh to deliver active pharmaceutical ingredients (APIs) directly to tumor sites, thereby minimizing systemic side effects associated with traditional therapies. Their flagship product, the MediChip, is designed to administer FDA-approved high-dose systemic therapies in a localized and sustained manner, enhancing the quality of patient care. Current research is focused on applications for pancreatic and lung cancers, with plans to expand the pipeline to include other types such as colorectal, breast, and stomach cancers. By targeting drug delivery directly to cancerous tissues, BioSapien aims to improve treatment efficacy while reducing toxicity for patients.

unspun

Series A in 2023
Unspun, Inc., founded in 2015 and based in San Francisco, California, specializes in the development of a platform that creates customized jeans using advanced body scanning technology, fit algorithms, and additive manufacturing. The company aims to address environmental concerns by reducing global carbon emissions through automated and localized manufacturing processes. Unspun’s innovative approach not only eliminates pattern-cutting waste and unsold inventory but also allows for the production of jeans in under ten minutes in a zero-waste manner. Their technology is showcased through the unspun.io platform, which provides digital customization solutions for various apparel brands. With a mission to make fashion more sustainable, Unspun is positioned at the intersection of robotics and digital apparel, striving to transform the industry with its unique approach to on-demand manufacturing.

MAA'VA

Seed Round in 2023
MAA'VA is focused on creating innovative green building materials designed to serve as sustainable alternatives to concrete. The company incorporates recycled plastics, utilizes carbon sequestration techniques, and promotes the upcycling of manufacturing waste. By addressing pressing issues such as the river sand shortage, water scarcity, climate change, and rapid urbanization, MAA'VA aims to provide eco-friendly solutions for construction. Its materials are suitable for both traditional and three-dimensional printing methods, enabling clients to adopt more sustainable practices in their building projects.

BioSapien

Series A in 2022
BioSapien is a pre-clinical biotechnology company focused on creating innovative biodegradable implantable products for oncology applications. The company is developing a 3D-printed drug delivery platform that utilizes a biodegradable mesh to deliver active pharmaceutical ingredients (APIs) directly to tumor sites, thereby minimizing systemic side effects associated with traditional therapies. Their flagship product, the MediChip, is designed to administer FDA-approved high-dose systemic therapies in a localized and sustained manner, enhancing the quality of patient care. Current research is focused on applications for pancreatic and lung cancers, with plans to expand the pipeline to include other types such as colorectal, breast, and stomach cancers. By targeting drug delivery directly to cancerous tissues, BioSapien aims to improve treatment efficacy while reducing toxicity for patients.

Looking Glass

Series B in 2022
Looking Glass Factory, established in 2014, is a technology company based in Brooklyn, New York, with a subsidiary in Hong Kong. It specializes in developing and manufacturing holographic displays, designed primarily for 3D creators. The company's flagship product, Looking Glass, is a desktop holographic display that combines light field and volumetric display technologies, enabling users to create, share, and interact with 3D content without the need for VR or AR headsets. Additionally, Looking Glass Factory offers volumetric printing services and software to manage its holographic displays. Its solutions cater to various industries, including drug discovery, medical visualization, experiential marketing, and 3D storytelling.

Terran Robotics

Seed Round in 2022
Terran Robotics is a construction company based in Bloomington, Indiana, that focuses on innovative home construction services, particularly in automated adobe wall building. The company utilizes artificial intelligence and robotics to enhance traditional earthen building techniques. By employing a custom-designed cable-driven robot for three-dimensional printing of homes, Terran Robotics aims to improve durability with features such as fire resistance and superior sound dampening. This approach enables clients to significantly reduce housing costs, lower energy expenses, and maintain an environmentally friendly footprint.

MAA'VA

Seed Round in 2022
MAA'VA is focused on creating innovative green building materials designed to serve as sustainable alternatives to concrete. The company incorporates recycled plastics, utilizes carbon sequestration techniques, and promotes the upcycling of manufacturing waste. By addressing pressing issues such as the river sand shortage, water scarcity, climate change, and rapid urbanization, MAA'VA aims to provide eco-friendly solutions for construction. Its materials are suitable for both traditional and three-dimensional printing methods, enabling clients to adopt more sustainable practices in their building projects.

Looking Glass

Convertible Note in 2022
Looking Glass Factory, established in 2014, is a technology company based in Brooklyn, New York, with a subsidiary in Hong Kong. It specializes in developing and manufacturing holographic displays, designed primarily for 3D creators. The company's flagship product, Looking Glass, is a desktop holographic display that combines light field and volumetric display technologies, enabling users to create, share, and interact with 3D content without the need for VR or AR headsets. Additionally, Looking Glass Factory offers volumetric printing services and software to manage its holographic displays. Its solutions cater to various industries, including drug discovery, medical visualization, experiential marketing, and 3D storytelling.

Prellis Biologics

Series C in 2022
Prellis Biologics, Inc. specializes in creating human tissues for drug development and the eventual production of human organs for transplantation. Founded in 2016 and based in San Francisco, California, the company employs advanced bioprinting technology to develop vascularized human tissues and organs, aiming to overcome the challenges associated with microvasculature. Its innovative products include TissueWorkshop, Organoids, Vascular Bundles, Tissue Chips, and Holograph X. Prellis Biologics also focuses on accurately replicating the human immune response through lymph node organoids, which can be utilized for various applications such as antibody discovery and immunogenicity assessment. By addressing critical issues in early-stage drug development and translational pharmacology, Prellis Biologics seeks to improve patient outcomes in healthcare.

Briefcase Biotec

Convertible Note in 2022
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.

BioSapien

Seed Round in 2021
BioSapien is a pre-clinical biotechnology company focused on creating innovative biodegradable implantable products for oncology applications. The company is developing a 3D-printed drug delivery platform that utilizes a biodegradable mesh to deliver active pharmaceutical ingredients (APIs) directly to tumor sites, thereby minimizing systemic side effects associated with traditional therapies. Their flagship product, the MediChip, is designed to administer FDA-approved high-dose systemic therapies in a localized and sustained manner, enhancing the quality of patient care. Current research is focused on applications for pancreatic and lung cancers, with plans to expand the pipeline to include other types such as colorectal, breast, and stomach cancers. By targeting drug delivery directly to cancerous tissues, BioSapien aims to improve treatment efficacy while reducing toxicity for patients.

unspun

Series A in 2021
Unspun, Inc., founded in 2015 and based in San Francisco, California, specializes in the development of a platform that creates customized jeans using advanced body scanning technology, fit algorithms, and additive manufacturing. The company aims to address environmental concerns by reducing global carbon emissions through automated and localized manufacturing processes. Unspun’s innovative approach not only eliminates pattern-cutting waste and unsold inventory but also allows for the production of jeans in under ten minutes in a zero-waste manner. Their technology is showcased through the unspun.io platform, which provides digital customization solutions for various apparel brands. With a mission to make fashion more sustainable, Unspun is positioned at the intersection of robotics and digital apparel, striving to transform the industry with its unique approach to on-demand manufacturing.

Looking Glass

Series A in 2021
Looking Glass Factory, established in 2014, is a technology company based in Brooklyn, New York, with a subsidiary in Hong Kong. It specializes in developing and manufacturing holographic displays, designed primarily for 3D creators. The company's flagship product, Looking Glass, is a desktop holographic display that combines light field and volumetric display technologies, enabling users to create, share, and interact with 3D content without the need for VR or AR headsets. Additionally, Looking Glass Factory offers volumetric printing services and software to manage its holographic displays. Its solutions cater to various industries, including drug discovery, medical visualization, experiential marketing, and 3D storytelling.

Prellis Biologics

Series B in 2021
Prellis Biologics, Inc. specializes in creating human tissues for drug development and the eventual production of human organs for transplantation. Founded in 2016 and based in San Francisco, California, the company employs advanced bioprinting technology to develop vascularized human tissues and organs, aiming to overcome the challenges associated with microvasculature. Its innovative products include TissueWorkshop, Organoids, Vascular Bundles, Tissue Chips, and Holograph X. Prellis Biologics also focuses on accurately replicating the human immune response through lymph node organoids, which can be utilized for various applications such as antibody discovery and immunogenicity assessment. By addressing critical issues in early-stage drug development and translational pharmacology, Prellis Biologics seeks to improve patient outcomes in healthcare.

Prellis Biologics

Convertible Note in 2021
Prellis Biologics, Inc. specializes in creating human tissues for drug development and the eventual production of human organs for transplantation. Founded in 2016 and based in San Francisco, California, the company employs advanced bioprinting technology to develop vascularized human tissues and organs, aiming to overcome the challenges associated with microvasculature. Its innovative products include TissueWorkshop, Organoids, Vascular Bundles, Tissue Chips, and Holograph X. Prellis Biologics also focuses on accurately replicating the human immune response through lymph node organoids, which can be utilized for various applications such as antibody discovery and immunogenicity assessment. By addressing critical issues in early-stage drug development and translational pharmacology, Prellis Biologics seeks to improve patient outcomes in healthcare.

Jointechlabs

Pre Seed Round in 2021
JointechLabs, Inc. is a company that specializes in point-of-care regenerative medicine therapies, headquartered in Brandon, Florida. The organization develops innovative medical devices, including the MiniTC® for the United States and the Mini-Stem System® for international markets. These devices facilitate the processing of autologous body fat, enabling safe and efficient use in non-surgical orthopedic and aesthetic procedures within medical offices. By providing a closed-loop disposable system for human tissue processing, JointechLabs simplifies the creation of high-quality injectable fat grafts and fat-derived stem cells, making individualized cell and tissue-based therapies more accessible and cost-effective for hospitals and clinics. Additionally, the company is expanding its product pipeline to include biologic drugs and 3D bioprinted products aimed at orthopedic, wound healing, and plastic and reconstructive surgery applications.

Prellis Biologics

Convertible Note in 2020
Prellis Biologics, Inc. specializes in creating human tissues for drug development and the eventual production of human organs for transplantation. Founded in 2016 and based in San Francisco, California, the company employs advanced bioprinting technology to develop vascularized human tissues and organs, aiming to overcome the challenges associated with microvasculature. Its innovative products include TissueWorkshop, Organoids, Vascular Bundles, Tissue Chips, and Holograph X. Prellis Biologics also focuses on accurately replicating the human immune response through lymph node organoids, which can be utilized for various applications such as antibody discovery and immunogenicity assessment. By addressing critical issues in early-stage drug development and translational pharmacology, Prellis Biologics seeks to improve patient outcomes in healthcare.

Looking Glass

Series A in 2020
Looking Glass Factory, established in 2014, is a technology company based in Brooklyn, New York, with a subsidiary in Hong Kong. It specializes in developing and manufacturing holographic displays, designed primarily for 3D creators. The company's flagship product, Looking Glass, is a desktop holographic display that combines light field and volumetric display technologies, enabling users to create, share, and interact with 3D content without the need for VR or AR headsets. Additionally, Looking Glass Factory offers volumetric printing services and software to manage its holographic displays. Its solutions cater to various industries, including drug discovery, medical visualization, experiential marketing, and 3D storytelling.

Briefcase Biotec

Convertible Note in 2020
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.

BioSapien

Convertible Note in 2020
BioSapien is a pre-clinical biotechnology company focused on creating innovative biodegradable implantable products for oncology applications. The company is developing a 3D-printed drug delivery platform that utilizes a biodegradable mesh to deliver active pharmaceutical ingredients (APIs) directly to tumor sites, thereby minimizing systemic side effects associated with traditional therapies. Their flagship product, the MediChip, is designed to administer FDA-approved high-dose systemic therapies in a localized and sustained manner, enhancing the quality of patient care. Current research is focused on applications for pancreatic and lung cancers, with plans to expand the pipeline to include other types such as colorectal, breast, and stomach cancers. By targeting drug delivery directly to cancerous tissues, BioSapien aims to improve treatment efficacy while reducing toxicity for patients.

BioSapien

Seed Round in 2019
BioSapien is a pre-clinical biotechnology company focused on creating innovative biodegradable implantable products for oncology applications. The company is developing a 3D-printed drug delivery platform that utilizes a biodegradable mesh to deliver active pharmaceutical ingredients (APIs) directly to tumor sites, thereby minimizing systemic side effects associated with traditional therapies. Their flagship product, the MediChip, is designed to administer FDA-approved high-dose systemic therapies in a localized and sustained manner, enhancing the quality of patient care. Current research is focused on applications for pancreatic and lung cancers, with plans to expand the pipeline to include other types such as colorectal, breast, and stomach cancers. By targeting drug delivery directly to cancerous tissues, BioSapien aims to improve treatment efficacy while reducing toxicity for patients.

unspun

Seed Round in 2019
Unspun, Inc., founded in 2015 and based in San Francisco, California, specializes in the development of a platform that creates customized jeans using advanced body scanning technology, fit algorithms, and additive manufacturing. The company aims to address environmental concerns by reducing global carbon emissions through automated and localized manufacturing processes. Unspun’s innovative approach not only eliminates pattern-cutting waste and unsold inventory but also allows for the production of jeans in under ten minutes in a zero-waste manner. Their technology is showcased through the unspun.io platform, which provides digital customization solutions for various apparel brands. With a mission to make fashion more sustainable, Unspun is positioned at the intersection of robotics and digital apparel, striving to transform the industry with its unique approach to on-demand manufacturing.

unspun

Seed Round in 2018
Unspun, Inc., founded in 2015 and based in San Francisco, California, specializes in the development of a platform that creates customized jeans using advanced body scanning technology, fit algorithms, and additive manufacturing. The company aims to address environmental concerns by reducing global carbon emissions through automated and localized manufacturing processes. Unspun’s innovative approach not only eliminates pattern-cutting waste and unsold inventory but also allows for the production of jeans in under ten minutes in a zero-waste manner. Their technology is showcased through the unspun.io platform, which provides digital customization solutions for various apparel brands. With a mission to make fashion more sustainable, Unspun is positioned at the intersection of robotics and digital apparel, striving to transform the industry with its unique approach to on-demand manufacturing.

Briefcase Biotec

Convertible Note in 2018
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.

Prellis Biologics

Convertible Note in 2018
Prellis Biologics, Inc. specializes in creating human tissues for drug development and the eventual production of human organs for transplantation. Founded in 2016 and based in San Francisco, California, the company employs advanced bioprinting technology to develop vascularized human tissues and organs, aiming to overcome the challenges associated with microvasculature. Its innovative products include TissueWorkshop, Organoids, Vascular Bundles, Tissue Chips, and Holograph X. Prellis Biologics also focuses on accurately replicating the human immune response through lymph node organoids, which can be utilized for various applications such as antibody discovery and immunogenicity assessment. By addressing critical issues in early-stage drug development and translational pharmacology, Prellis Biologics seeks to improve patient outcomes in healthcare.

Giroptic

Convertible Note in 2017
Giroptic is a company that specializes in the development of innovative imaging technology, particularly through its patented real-time image fusion process. The firm gained significant attention with the launch of its first consumer product, the Giroptic 360cam, which was funded through a successful Kickstarter campaign in 2014, raising over $1.4 million and establishing itself as a major player in France’s crowdfunding landscape. The 360cam is a digital camera designed to capture immersive 360-degree panoramic images, allowing users to communicate and share their experiences in a more engaging manner. Giroptic aims to lead the evolution of immersive photography and videography for both consumers and professionals.

Eng X

Convertible Note in 2017
EngX automates the production of custom products by integrating assembly, wiring with 3D printing.They slash production costs, time & errors.

Prellis Biologics

Seed Round in 2017
Prellis Biologics, Inc. specializes in creating human tissues for drug development and the eventual production of human organs for transplantation. Founded in 2016 and based in San Francisco, California, the company employs advanced bioprinting technology to develop vascularized human tissues and organs, aiming to overcome the challenges associated with microvasculature. Its innovative products include TissueWorkshop, Organoids, Vascular Bundles, Tissue Chips, and Holograph X. Prellis Biologics also focuses on accurately replicating the human immune response through lymph node organoids, which can be utilized for various applications such as antibody discovery and immunogenicity assessment. By addressing critical issues in early-stage drug development and translational pharmacology, Prellis Biologics seeks to improve patient outcomes in healthcare.

Looking Glass

Series A in 2017
Looking Glass Factory, established in 2014, is a technology company based in Brooklyn, New York, with a subsidiary in Hong Kong. It specializes in developing and manufacturing holographic displays, designed primarily for 3D creators. The company's flagship product, Looking Glass, is a desktop holographic display that combines light field and volumetric display technologies, enabling users to create, share, and interact with 3D content without the need for VR or AR headsets. Additionally, Looking Glass Factory offers volumetric printing services and software to manage its holographic displays. Its solutions cater to various industries, including drug discovery, medical visualization, experiential marketing, and 3D storytelling.

Eng X

Seed Round in 2017
EngX automates the production of custom products by integrating assembly, wiring with 3D printing.They slash production costs, time & errors.

Solidface Technology

Seed Round in 2016
Solidface Technology Inc., founded in 2013 and based in Austin, Texas, specializes in multipurpose 3D modeling software. The company's flagship product, SolidFace, is a cloud-based CAD system that facilitates collaboration among designers and engineers across various disciplines. This software allows users to work together in real time, with built-in version control to ensure that the latest iterations of designs are easily accessible. SolidFace combines the robust capabilities of the Parasolid 3D modeler core with over 15 years of development experience in 2D and 3D modeling. It offers advanced features for detailing, solid modeling, assembly, and parameterization, ultimately enhancing the design cycle and improving return on investment for its users.

Giroptic

Seed Round in 2016
Giroptic is a company that specializes in the development of innovative imaging technology, particularly through its patented real-time image fusion process. The firm gained significant attention with the launch of its first consumer product, the Giroptic 360cam, which was funded through a successful Kickstarter campaign in 2014, raising over $1.4 million and establishing itself as a major player in France’s crowdfunding landscape. The 360cam is a digital camera designed to capture immersive 360-degree panoramic images, allowing users to communicate and share their experiences in a more engaging manner. Giroptic aims to lead the evolution of immersive photography and videography for both consumers and professionals.

Electroloom

Convertible Note in 2016
Electroloom is a San Francisco-based company founded in 2013 that specializes in 3D printing services for fabrics. Utilizing a unique manufacturing process known as Field Guided Fabrication, Electroloom is capable of producing lightweight, seamless fabrics on demand. This method closely resembles traditional 3D printing and enables the creation of customized apparel, particularly T-shirts and sweaters, as well as other fabric-based products such as tissue engineering scaffolds and filters. By focusing on the customization of fibrous articles of clothing, the company aims to meet the specific needs of the clothing industry, allowing for unique designs that enhance a stylist's collection.

Giroptic

Seed Round in 2015
Giroptic is a company that specializes in the development of innovative imaging technology, particularly through its patented real-time image fusion process. The firm gained significant attention with the launch of its first consumer product, the Giroptic 360cam, which was funded through a successful Kickstarter campaign in 2014, raising over $1.4 million and establishing itself as a major player in France’s crowdfunding landscape. The 360cam is a digital camera designed to capture immersive 360-degree panoramic images, allowing users to communicate and share their experiences in a more engaging manner. Giroptic aims to lead the evolution of immersive photography and videography for both consumers and professionals.

Looking Glass

Seed Round in 2015
Looking Glass Factory, established in 2014, is a technology company based in Brooklyn, New York, with a subsidiary in Hong Kong. It specializes in developing and manufacturing holographic displays, designed primarily for 3D creators. The company's flagship product, Looking Glass, is a desktop holographic display that combines light field and volumetric display technologies, enabling users to create, share, and interact with 3D content without the need for VR or AR headsets. Additionally, Looking Glass Factory offers volumetric printing services and software to manage its holographic displays. Its solutions cater to various industries, including drug discovery, medical visualization, experiential marketing, and 3D storytelling.

Structur3D Printing

Pre Seed Round in 2015
Structur3D Printing specializes in advancing 3D printing technology by enabling the use of paste materials alongside traditional plastic filaments. The company has developed a unique system that integrates the precision of Fused Deposition Modeling (FDM) printers with the versatile capabilities of paste extrusion. This innovation allows makers and 3D printing enthusiasts to create a diverse range of objects using materials such as silicone, polyurethane, latex, and even edible substances like icing sugar. By broadening the scope of 3D printing, Structur3D Printing empowers users to produce functional items tailored to specific applications, moving beyond the limitations of rigid plastics.

Maieutic Enterprises

Pre Seed Round in 2015
Maieutic Enterprises is a startup focused on developing innovative die and surface casting technologies for manufacturers utilizing die extrusions. The company is creating a patented solution known as the "programmable surface," which consists of an array of adjustable pins. By manipulating the heights of these pins using Lorentz force, manufacturers can replicate various surface topographies and address surface deformations that occur over time due to wear and tear. This technology enables manufacturers to make precise adjustments for surface variations without incurring downtime, thus improving efficiency and reducing costs during the production process.

Grasp

Venture Round in 2015
Grasp manufactures and distributes a range of personalized prosthetics that are manufactured using 3D printers to its clients. It is based in Portland.

Briefcase Biotec

Series A in 2015
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.

Ouro_botics

Seed Round in 2015
Ouro_botics, founded by Jemma Redmond in Dublin, specializes in developing affordable modular bioprinting technology aimed at researchers in the biotech sector. The company emerged from Redmond's academic exploration of osteoblast adhesion, which led her to realize the potential of bioprinting for advancing medical applications. Ouro_botics addresses the gaps in the market by offering a high-precision 3D bioprinter that achieves an accuracy of 10 microns and supports various types of extruder heads. This versatility allows researchers to experiment with different biomaterials such as gelatine, alginate, chitosan, and keratin, enhancing their ability to conduct tissue growth studies and accelerate medical research. Currently, the company is providing a limited number of development kits available for pre-order, making advanced bioprinting technology accessible to students, biohackers, and researchers.

Electroloom

Seed Round in 2015
Electroloom is a San Francisco-based company founded in 2013 that specializes in 3D printing services for fabrics. Utilizing a unique manufacturing process known as Field Guided Fabrication, Electroloom is capable of producing lightweight, seamless fabrics on demand. This method closely resembles traditional 3D printing and enables the creation of customized apparel, particularly T-shirts and sweaters, as well as other fabric-based products such as tissue engineering scaffolds and filters. By focusing on the customization of fibrous articles of clothing, the company aims to meet the specific needs of the clothing industry, allowing for unique designs that enhance a stylist's collection.

Pembient

Pre Seed Round in 2015
Pembient, Inc. is a biotechnology company founded in 2015 and based in Seattle, Washington, that specializes in producing synthetic wildlife products, including rhino horn and elephant ivory. Utilizing advances in biotechnology, Pembient fabricates these materials through DNA and 3D-printing techniques, creating carvable horns suitable for durable goods such as jewelry and libation cups. The company's mission is to combat the illegal wildlife trade, a significant black market valued at $20 billion, by offering affordable alternatives that can deter poaching. By replacing traditional wildlife products with bio-fabricated options, Pembient aims to promote sustainable commerce and support wildlife conservation efforts.

Rational Robotics

Convertible Note in 2015
Rational Robotics is a manufacturer based in Edmonton, Canada, specializing in automatic coating robots. The company designs and develops robotic machines that provide auto body repainting services, utilizing advanced technology such as 3D scanning and custom algorithms to optimize tool paths for painting. Their robots incorporate computer vision to automate the painting process, ensuring high levels of accuracy and quality across various sizes of objects. By enhancing and automating part painting, Rational Robotics offers efficient solutions for enterprises seeking to improve their painting operations.

Ouro_botics

Venture Round in 2015
Ouro_botics, founded by Jemma Redmond in Dublin, specializes in developing affordable modular bioprinting technology aimed at researchers in the biotech sector. The company emerged from Redmond's academic exploration of osteoblast adhesion, which led her to realize the potential of bioprinting for advancing medical applications. Ouro_botics addresses the gaps in the market by offering a high-precision 3D bioprinter that achieves an accuracy of 10 microns and supports various types of extruder heads. This versatility allows researchers to experiment with different biomaterials such as gelatine, alginate, chitosan, and keratin, enhancing their ability to conduct tissue growth studies and accelerate medical research. Currently, the company is providing a limited number of development kits available for pre-order, making advanced bioprinting technology accessible to students, biohackers, and researchers.

Clawz

Seed Round in 2014
Clawz is a Shanghai-based company that specializes in designing and producing three-dimensional printed fingernail jewelry. Founded in 2014, Clawz offers its products in various metal options, including silver, brass, and gold. The fingernail jewelry can be easily applied using an adhesive sticker, allowing for quick and damage-free removal from the natural nail or nail polish. This innovative approach enables users to enjoy reusable and stylish nail adornments with minimal effort. Clawz also provides online ordering services, making it convenient for customers to access their unique nail art products.

Voltera

Pre Seed Round in 2014
Voltera is a technology company focused on advancing additive and flexible electronics through innovative prototyping tools. The company's flagship circuit board printer is designed to assist engineers in accelerating hardware development, allowing for faster iteration and customization of electronic products. By providing solutions for students, product developers, and researchers, Voltera supports a range of applications from educational initiatives to cutting-edge product design. Its tools facilitate quick experimentation and innovation, making it easier for organizations worldwide to explore new materials and methods in electronics.

Clawz

Pre Seed Round in 2014
Clawz is a Shanghai-based company that specializes in designing and producing three-dimensional printed fingernail jewelry. Founded in 2014, Clawz offers its products in various metal options, including silver, brass, and gold. The fingernail jewelry can be easily applied using an adhesive sticker, allowing for quick and damage-free removal from the natural nail or nail polish. This innovative approach enables users to enjoy reusable and stylish nail adornments with minimal effort. Clawz also provides online ordering services, making it convenient for customers to access their unique nail art products.

Rational Robotics

Pre Seed Round in 2014
Rational Robotics is a manufacturer based in Edmonton, Canada, specializing in automatic coating robots. The company designs and develops robotic machines that provide auto body repainting services, utilizing advanced technology such as 3D scanning and custom algorithms to optimize tool paths for painting. Their robots incorporate computer vision to automate the painting process, ensuring high levels of accuracy and quality across various sizes of objects. By enhancing and automating part painting, Rational Robotics offers efficient solutions for enterprises seeking to improve their painting operations.

Photon Fluid

Venture Round in 2014
Starts the next generation of 3D printer.

Kast

Seed Round in 2014
Kast is a United States-based company that specializes in the development of advanced stereolithographic 3D printers. The company is recognized for pioneering next-generation 3D printing technology, focusing on innovative solutions that enhance the capabilities and applications of additive manufacturing. Through its cutting-edge products, Kast aims to meet the evolving needs of various industries that rely on precise and efficient 3D printing processes.

Briefcase Biotec

Seed Round in 2014
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.

Rational Robotics

Venture Round in 2013
Rational Robotics is a manufacturer based in Edmonton, Canada, specializing in automatic coating robots. The company designs and develops robotic machines that provide auto body repainting services, utilizing advanced technology such as 3D scanning and custom algorithms to optimize tool paths for painting. Their robots incorporate computer vision to automate the painting process, ensuring high levels of accuracy and quality across various sizes of objects. By enhancing and automating part painting, Rational Robotics offers efficient solutions for enterprises seeking to improve their painting operations.

Formlabs

Series A in 2013
Formlabs Inc. is a company that designs and manufactures advanced 3D printing systems targeted at engineers, designers, and artists. Established in 2011 and headquartered in Somerville, Massachusetts, Formlabs offers a diverse range of products, including the Form 3, Form 3B, and Form 3L printers, all utilizing Low Force Stereolithography (LFS) technology. The company also provides post-processing solutions such as Form Wash and Form Cure, as well as the Fuse 1 SLS 3D printer and the Form Cell manufacturing solution. Formlabs develops high-performance materials for various applications in industries like dental, healthcare, jewelry, and education. Its PreForm software facilitates the preparation of models for printing, making it a preferred choice among professionals worldwide. With additional offices in Germany, Japan, China, Singapore, Hungary, and North Carolina, Formlabs continues to innovate in the field of 3D printing, enhancing the capabilities of digital fabrication.

FlexLab

Angel Round in 2013
FlexLab is an innovative laboratory focused on intelligent manufacturing and digital fabrication. Founded in 2013, it brings together a diverse team of software engineers, electronic engineers, designers, and other interdisciplinary professionals committed to advancing technology in various sectors, including transportation, education, and retail. The lab has successfully launched several projects, notably the Flexbot, a 3D printed nano copter that gained significant support on Kickstarter, and FlexPV, which won first prize at the Michelin Challenge Bibendum. FlexLab's offerings include mobile applications for controlling customized drones, as well as advancements in areas such as self-driving technology, drones, unattended retailing, virtual reality, remote robotics, image recognition, sustainable vehicles, voice recognition, and soft robotics. Its products have reached users in over twenty countries, reflecting a global commitment to innovation and creativity.

Formlabs

Seed Round in 2011
Formlabs Inc. is a company that designs and manufactures advanced 3D printing systems targeted at engineers, designers, and artists. Established in 2011 and headquartered in Somerville, Massachusetts, Formlabs offers a diverse range of products, including the Form 3, Form 3B, and Form 3L printers, all utilizing Low Force Stereolithography (LFS) technology. The company also provides post-processing solutions such as Form Wash and Form Cure, as well as the Fuse 1 SLS 3D printer and the Form Cell manufacturing solution. Formlabs develops high-performance materials for various applications in industries like dental, healthcare, jewelry, and education. Its PreForm software facilitates the preparation of models for printing, making it a preferred choice among professionals worldwide. With additional offices in Germany, Japan, China, Singapore, Hungary, and North Carolina, Formlabs continues to innovate in the field of 3D printing, enhancing the capabilities of digital fabrication.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.